ABOUT THE COVER
STOCKHOLDER
LETTER
FINANCIAL
HIGHLIGHTS
FORM 10K
PROXY
CORPORATE
INFORMATION
DOWNLOADS |
| |
PART II Item 6. |
Selected Financial Data |
|
|
|
Consolidated Statement of Operations Data
Five years ended April 3, 2004
(In thousands, except per share amounts)
| |
2004(5) |
|
2003(4) |
|
2002(3) |
|
2001(2) |
|
2000(1) |
 |
| Net revenues |
$1,397,846 |
|
$1,155,977 |
|
$1,015,579 |
|
$1,659,358 |
|
$1,020,993 |
| Operating income (loss) |
327,135 |
|
155,669 |
|
(24,750 |
) |
384,053 |
|
322,192 |
Income (loss) before income taxes and
equity in joint venture |
350,544 |
|
169,872 |
|
(192,954 |
) |
61,103 |
|
1,024,272 |
| Provision (benefit) for income taxes |
47,555 |
|
44,167 |
|
(79,347 |
) |
25,845 |
|
378,006 |
| Net income (loss) |
302,989 |
|
125,705 |
|
(113,607 |
) |
35,258 |
|
652,450 |
| Net income (loss) per share : |
|
|
|
|
|
|
|
|
|
| Basic |
$0.89 |
|
$0.37 |
|
$(0.34 |
) |
$0.11 |
|
$2.06 |
| Diluted |
$0.85 |
|
$0.36 |
|
$(0.34 |
) |
$0.10 |
|
$1.90 |
| Shares used in per share calculations: |
|
|
|
|
|
|
|
|
|
| Basic |
341,427 |
|
337,069 |
|
333,556 |
|
328,196 |
|
316,724 |
| Diluted |
354,551 |
|
348,622 |
|
333,556 |
|
353,345 |
|
343,479 |
| |
|
|
|
|
|
|
|
|
|
| |
|
| (1) |
Net income includes pre-tax capital gain of $674,728 ($398,089 net of tax) from UMC/USIC merger. |
| (2) |
Net income includes pre-tax write-down of $362,124 ($219,085 net of tax) on UMC investment. |
| (3) |
Net loss includes pre-tax write-down of $191,852 ($116,070 net of tax) on UMC investment, $25,336 impairment loss on intangibles and other assets and lawsuit settlement gain of $19,400. The change in operating income (loss) compared to the number shown in the fiscal 2003 Form 10-K of $19,400 is due to a reclassification of the Altera Corporation lawsuit settlement on the consolidated statement of operations from a separate line after operating income (loss) to be included within operating income (loss). |
| (4) |
Net income includes impairment loss on excess facilities and equipment of $54,691 and impairment loss on investments of $10,425. |
| (5) |
Net income includes a $34,418 reduction in taxes associated with an IRS tax settlement, impairment loss on excess facilities of $3,376, litigation settlement and contingency of $6,400 and write-off of acquired in-process research and development of $6,969 related to the acquisition of Triscend. |
Consolidated Balance Sheet Data
Five Years Ended April 3, 2004
(In thousands)
| |
2004 |
|
2003 |
|
2002 |
|
2001 |
|
2000 |
|
| Working capital |
$ 920,422 |
|
$ 861,448 |
|
$ 802,913 |
|
$ 751,469 |
|
$ 796,213 |
| Total assets |
2,937,473 |
|
2,421,676 |
|
2,335,360 |
|
2,502,196 |
|
2,348,639 |
| Stockholders' equity |
2,483,062 |
|
1,950,739 |
|
1,903,740 |
|
1,918,316 |
|
1,776,655 |
|
|